Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. | Front Immunol | 2022 | 36119022 | PubTator, text mining | PubMed |
| Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker. | Front Genet | 2022 | 36118871 | PubTator, text mining | PubMed |
| Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence. | BMC Genomics | 2022 | 36114454 | PubTator, text mining | PubMed |
| Comparison of single‑nucleus and single‑cell transcriptomes in hepatocellular carcinoma tissue. | Mol Med Rep | 2022 | 36111491 | PubTator, text mining | PubMed |
| Prognostic model based on m6A-associated lncRNAs in esophageal cancer. | Front Endocrinol (Lausanne) | 2022 | 36111294 | PubTator, text mining | PubMed |
| SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma. | Front Oncol | 2022 | 36110969 | PubTator, text mining | PubMed |
| Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. | Front Genet | 2022 | 36110218 | PubTator, text mining | PubMed |
| Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment. | JCI Insight | 2022 | 36107619 | PubTator, text mining | PubMed |
| Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice. | Oncoimmunology | 2022 | 36105746 | PubTator, text mining | PubMed |
| Identification of N7-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma. | Front Genet | 2022 | 36105111 | PubTator, text mining | PubMed |
| Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy. | J Immunother Cancer | 2022 | 36100308 | PubTator, text mining | PubMed |
| The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma. | Cancer Discov | 2022 | 36098652 | PubTator, text mining | PubMed |
| Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer. | Front Genet | 2022 | 36092873 | PubTator, text mining | PubMed |
| Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma. | Front Cell Dev Biol | 2022 | 36092724 | PubTator, text mining | PubMed |
| Bone marrow free immune checkpoints as a potential biomarker for differential diagnosis of acquired bone marrow failures. | J Clin Lab Anal | 2022 | 36086857 | PubTator, text mining | PubMed |
| Artificial intelligence-driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi-center integration analysis. | Mol Oncol | 2022 | 36083778 | PubTator, text mining | PubMed |
| Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics. | Heliyon | 2022 | 36082331 | PubTator, text mining | PubMed |
| An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. | Front Genet | 2022 | 36081989 | PubTator, text mining | PubMed |
| BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM. | Front Immunol | 2022 | 36081508 | PubTator, text mining | PubMed |
| Genetic Mouse Models to Study Pancreatic Cancer-Induced Pain and Reduction in Well-Being. | Cells | 2022 | 36078040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=50